Recently, Danone CEO Antoine de Saint-Affrique appeared in Shanghai and engaged in discussions with media outlets, including Foodinc.

Danone's global CEO, Antoine de Saint-Affrique, emphasized the central role of the Chinese market in Danone's "Renew Danone" strategy and shared the impressive performance of Danone China, with an 8% year-on-year business growth in the first half of the year, largely driven by sales volume. He believes that the competition in the Chinese market is healthy, helping Danone stay alert and focused. Danone's main brands in China include Aptamil, Nutrilon, Mizone, Evian, and Nutricia, covering categories such as infant formula, beverages, and medical nutrition products.

Antoine mentioned that Danone will leverage scientific research and digital technologies, such as AI and big data, to contribute to the wellness sector and drive the development of the medical nutrition field. Danone’s strategic focus includes the scientific and differentiated approach to infant formula, the development of gut health and high-protein businesses, and continued investment in medical nutrition. The Danone China team has been highly praised by Saint-Affrique for its efficient execution and deep understanding of the market.

Danone will continue to invest in China, including both hardware and software investments, such as factory construction, innovative product development, research, and talent cultivation. Saint-Affrique revealed that Danone will showcase innovative products and green practices at the 7th China International Import Expo (CIIE) to mark the 60th anniversary of diplomatic relations between China and France.

Danone's newly launched Aptamil Zhiyi infant formula, an ultra-premium product, has been introduced in Hong Kong and can be purchased through official cross-border channels in mainland China. This demonstrates the importance of the Chinese market to Danone and the demand from Chinese consumers for high-end products.

0

打赏

表情 点击这里取消回复。